These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
839 related items for PubMed ID: 15364445
1. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients. Kara IH, Yilmaz ME, Suner A, Kadiroglu AK, Isikoglu B. Vaccine; 2004 Sep 28; 22(29-30):3963-7. PubMed ID: 15364445 [Abstract] [Full Text] [Related]
2. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Halota W, Muszyńska M, Pawłowska M. Med Sci Monit; 2002 Jul 28; 8(7):CR516-9. PubMed ID: 12118201 [Abstract] [Full Text] [Related]
3. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors]. Chlíbek R, Smetana J, Sindelár R, Cecetková B, Prymula R, Kohl I. Epidemiol Mikrobiol Imunol; 2007 Aug 28; 56(3):119-28. PubMed ID: 17900060 [Abstract] [Full Text] [Related]
6. Immunogenicity of hepatitis B vaccine in multi-transfused thalassemic patients with and without hepatitis C infection: a comparative study with healthy controls. Froutan-Pishbijari H, Ghofrani H, Mirmomenm S, Kazemi-Asl S, Nassiri-Toosi M, Farahvash MJ, Toroghi HH, Aminian K, Mansour-Ghanaei F, Bagherzadeh AH. Med Sci Monit; 2004 Dec 28; 10(12):CR679-83. PubMed ID: 15567986 [Abstract] [Full Text] [Related]
10. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients]. Urbanowicz W. Przegl Epidemiol; 2000 Dec 28; 54(3-4):343-50. PubMed ID: 11349597 [Abstract] [Full Text] [Related]
13. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Liver Int; 2005 Dec 28; 25(6):1162-8. PubMed ID: 16343067 [Abstract] [Full Text] [Related]
14. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients. Sorkhi H, Dooki MR, Ebrahimnejad MS. J Med Assoc Thai; 2006 Oct 28; 89(10):1648-53. PubMed ID: 17128839 [Abstract] [Full Text] [Related]
15. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I. HIV Med; 2007 Jul 28; 8(5):295-9. PubMed ID: 17561875 [Abstract] [Full Text] [Related]
16. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC. Mikrobiyol Bul; 2007 Apr 28; 41(2):227-33. PubMed ID: 17682709 [Abstract] [Full Text] [Related]
18. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. Rajapurkar MM, Gang S, Dabhi M, Kulkarni PS. J Nephrol; 2007 Apr 28; 20(5):596-601. PubMed ID: 17918146 [Abstract] [Full Text] [Related]
19. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. Pediatr Infect Dis J; 2008 Oct 28; 27(10):881-5. PubMed ID: 18756185 [Abstract] [Full Text] [Related]